Delcath Systems Stock

Delcath Systems Financial Leverage

The Financial Leverage (Equity Multiplier) of Delcath Systems (DCTH) as of Aug 8, 2026 is 1.11. In the previous year, Financial Leverage (Equity Multiplier) was 1.11 — a change of -0.22% (lower).

Financial Leverage

1.11

YoY

-0.22%

Last updated:

Financial Leverage (Equity Multiplier) of Delcath Systems is 2026 1.11 . Financial Leverage (Equity Multiplier) of Delcath Systems was 2025 1.11 . It decreases by -0.22% lower compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Financial Leverage (Equity Multiplier) of Delcath Systems is 1.11 in 2026.

Financial Leverage (Equity Multiplier) of Delcath Systems changed from 1.11 to 1.11, representing a -0.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Delcath Systems with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Delcath Systems

All Key Metrics — Delcath Systems